A: Our total requirement plan was about USD 25 million, of which, USD 5 million was raised from Ridgeback, while USD 5 million was via ISP. Right now, IFC has not put in Rs 60 crore, but just USD 6 million, which should be around Rs 24 crore. We are also planning to raise the rest of the requirement - about USD 9 million - by way of term loan. We are discussing with IFC and are looking at a long-term term loan.

Q: Any further equity dilutions?

A: No, this is the final dilution that we are doing and this puts to close anything else in the near future.

Q: When are your new tablet plants coming up and how many are you setting up?

A: The tableting plants will be completed by end of June and we expect to start commercial production by August.

Q: What is the capacity of this plant and at full utilization how much will it add in terms of revenues to Granules in 2008?

A: In 2008, we are looking at about Rs 70-80 crore of revenues from the tableting plant, which will have a capacity of about six billion tablets per annum in the first year, which we expect to take to about 12 billion tablets in in the second year; we expect to utilize at least 80-85% of the capacity in the first and second year.

Q: Where are you using the rest of the money, part of it is going into the tablet plant: what is the remaining expansion plan and how much of it is in China?

A: Its for the tableting plant and for the acquisition in China, China is close to about USD 5 million and it is also part of the expansion of the APIs that we have completed and a little bit expansion going on in the APIs.

Q: Are you expecting to be hit at all by the dollar fall that we have seen over the past month?

A: We are hit to some extent but overall not as badly as one would think because about 50-60% of our raw materials are also imported and that directly gets translated into that and we are also negotiating with our customers for increases in sales prices.